Citigroup’s Microbot Medical MBOT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,866
| Closed | -$9.73K | – | 6207 |
|
|
2025
Q4 | $9.73K | Buy |
+4,866
| New | +$11.5K | ﹤0.01% | 5064 |
|
|
2025
Q3 | – | Sell |
-14,042
| Closed | -$35.4K | – | 6226 |
|
|
2025
Q2 | $35.4K | Buy |
+14,042
| New | +$33.6K | ﹤0.01% | 4919 |
|
|
2020
Q1 | – | Sell |
-2
| Closed | – | – | 7707 |
|
|
2019
Q4 | $0 | Sell |
2
-1
| -33% | -$6 | ﹤0.01% | 7749 |
|
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 7757 |
|
|
2019
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 7809 |
|
|
2019
Q1 | $0 | Sell |
3
-3,501
| -100% | -$27.2K | ﹤0.01% | 7738 |
|
|
2018
Q4 | $6K | Buy |
3,504
+3,500
| +87,500% | +$13.2K | ﹤0.01% | 7308 |
|
|
2018
Q3 | $0 | Buy |
4
+3
| +300% | +$26 | ﹤0.01% | 7817 |
|
|
2018
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7672 |
|
|
2018
Q1 | $0 | Buy |
+1
| New | +$14 | ﹤0.01% | 7609 |
|
|
2017
Q4 | – | Sell |
-1
| Closed | -$17 | – | 7607 |
|
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 7355 |
|
|
2017
Q2 | $0 | Sell |
1
-6
| -86% | -$331 | ﹤0.01% | 7425 |
|
|
2017
Q1 | $1K | Buy |
+7
| New | +$615 | ﹤0.01% | 7089 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 7261 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 7126 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 7259 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$528 | – | 7625 |
|
|
2015
Q4 | $0 | Sell |
1
-6
| -86% | -$4.41K | ﹤0.01% | 7733 |
|
|
2015
Q3 | $5K | Buy |
7
+4
| +133% | +$3.04K | ﹤0.01% | 6729 |
|
|
2015
Q2 | $2K | Buy |
3
+2
| +200% | +$2.35K | ﹤0.01% | 7135 |
|
|
2015
Q1 | $1K | Sell |
1
-5
| -83% | -$8.93K | ﹤0.01% | 7055 |
|
|
2014
Q4 | $10K | Buy |
6
+4
| +200% | +$7.26K | ﹤0.01% | 6474 |
|
|
2014
Q3 | $4K | Sell |
2
-1
| -33% | -$2.64K | ﹤0.01% | 6649 |
|
|
2014
Q2 | $9K | Sell |
3
-1
| -25% | -$2.31K | ﹤0.01% | 6216 |
|
|
2014
Q1 | $8K | Sell |
4
-4
| -50% | -$9.57K | ﹤0.01% | 6431 |
|
|
2013
Q4 | $17K | Buy |
+8
| New | +$16.9K | ﹤0.01% | 6225 |
|
|
2013
Q3 | – | Sell |
-1
| Closed | -$2.71K | – | 6680 |
|
|
2013
Q2 | $1K | Buy |
+1
| New | +$2.82K | ﹤0.01% | 6631 |
|
Other funds holding MBOT
VCM
CBU
AA
Citigroup's MBOT Position: Q1 2026 in Review
Citigroup sold out of Microbot Medical (MBOT) in Q1 2026, closing a stake of 4,866 shares — an estimated $9.73K sold.
Citigroup first reported a position in MBOT in Q2 2013 and held it in 23 quarters. The position peaked at $35.4K in Q2 2025. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.
- Citigroup reported no remaining Microbot Medical position as of Q1 2026 after selling out during the quarter.
- Citigroup sold 4,866 Microbot Medical shares in Q1 2026, an estimated $9.73K.
- Citigroup first reported a position in Microbot Medical in Q2 2013 and held it in 23 quarters.
- Citigroup's Microbot Medical position peaked at $35.4K in Q2 2025.
- 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.